MNKD
MANNKIND CORP
NASDAQ · Healthcare · Biotechnology · US
$3.09
+1.64%Leverage
- Debt / equity
- -4.92x
- Net debt / equity
- -4.14x
- Debt / assets
- 0.45x
- Debt / EBITDA
- 10.98x
- Net debt / EBITDA
- 9.22x
Liquidity & coverage
- Current ratio
- 1.72x
- Quick ratio
- 1.41x
- Cash ratio
- 0.78x
- Interest coverage
- 0.17x
- EBITDA / interest
- 0.67x
- Working capital
- $102.8M
Cash & dividend
- FCF / debt
- -0.06x
- Cash flow / debt
- -0.03x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026